 |
|
Does Aspirin Consumption Affect the Presentation or Severity of Acute Myocardial Infarction?
Nananda F. Col, MD, MPP;
Jorge Yarzebski, MD, MPH;
Joel M. Gore, MD;
Joseph S. Alpert, MD;
Robert J. Goldberg, PhD
Arch Intern Med. 1995;155(13):1386-1389.
Abstract
| |
Background
While consumption of aspirin has been shown to decrease the occurrence of nonfatal cardiac events, the majority of studies have not demonstrated any impact of aspirin intake on cardiovascular mortality. The present population-based study explores the possibility that aspirin consumption affects the presentation and severity of acute myocardial infarction (AMI), and hence the likelihood of clinical detection.
Methods
We monitored the use of aspirin before admission for 2114 patients with a validated diagnosis of AMI in 16 hospitals in the Worcester, Mass, metropolitan area during 1986, 1988, and 1990. The AMIs were characterized as Q wave vs non—Q wave and large (peak creatine kinase levels more than five times normal) vs small (peak creatine kinase levels less than two times normal).
Results
A total of 332 patients (16%) with validated AMI took aspirin before hospital admission. Nearly 65% of aspirin users had non—Q-wave AMIs, compared with 49% of nonaspirin users. Thirty percent of aspirin users sustained small AMIs, compared with 22% of nonaspirin users. These findings persisted after stratifying for previous AMI, history of coronary disease, receipt of thrombolytic therapy, and exclusion of early hospital deaths. Using multivariable regression models to control for age, gender, previous evidence of coronary disease, and use of other medications, prior aspirin consumption remained independently associated with AMI type (non—Q-wave AMI) and smaller infarct size.
Conclusion
Aspirin consumption appears to modify the presentation of AMI, increasing the likelihood that the infarct will be of the small, non—Q-wave variety.
(Arch Intern Med. 1995;155:1386-1389)
Author Affiliations
From the Department of Family and Community Medicine and the Department of Medicine, University of Massachusetts Medical School, Worcester (Drs Col, Yarzebski, Gore, and Goldberg), and the Department of Medicine, University of Arizona School of Medicine, Tucson (Dr Alpert).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Severity of Myocardial Infarction: New Insights on an Elusive Construct
Roger
Circulation 2009;119:489-491.
FULL TEXT
Prior Aspirin Use and Outcomes in Elderly Patients Hospitalized With Acute Myocardial Infarction
Portnay et al.
J Am Coll Cardiol 2005;46:967-974.
ABSTRACT
| FULL TEXT
Impact of Prior Use or Recent Withdrawal of Oral Antiplatelet Agents on Acute Coronary Syndromes
Collet et al.
Circulation 2004;110:2361-2367.
ABSTRACT
| FULL TEXT
Association of Statin Therapy with Outcomes of Acute Coronary Syndromes: The GRACE Study
Spencer et al.
ANN INTERN MED 2004;140:857-866.
ABSTRACT
| FULL TEXT
Longitudinal Trends in the Severity of Acute Myocardial Infarction: A Population Study in Olmsted County, Minnesota
Hellermann et al.
Am J Epidemiol 2002;156:246-253.
ABSTRACT
| FULL TEXT
Twenty-two year (1975 to 1997) trends in the incidence, in-hospital and long-term case fatality rates from initial q-wave and non-q-wave myocardial infarction: a multi-hospital, community-wide perspective
Furman et al.
J Am Coll Cardiol 2001;37:1571-1580.
ABSTRACT
| FULL TEXT
Determination of who may derive most benefit from aspirin in primary prevention: subgroup results from a randomised controlled trial
Meade and Brennan
BMJ 2000;321:13-17.
ABSTRACT
| FULL TEXT
Influence of previous aspirin treatment and smoking on the electrocardiographic manifestations of injury in acute myocardial infarction
Kennon et al.
Heart 2000;84:41-45.
ABSTRACT
| FULL TEXT
Coronary Events With Lipid-Lowering Therapy: The AFCAPS/TexCAPS Trial
Haq et al.
JAMA 1999;281:414-419.
FULL TEXT
Clinical characteristics determining the mode of presentation in patients with acute coronary syndromes
Kennon et al.
J Am Coll Cardiol 1998;32:2018-2022.
ABSTRACT
| FULL TEXT
MI MAY BE LESS SEVERE IN ASPIRIN USERS
JWatch General 1995;1995:1-1.
FULL TEXT
|
